Corporate News     11-Jan-22
Marksans Pharma receives USFDA approval for Cetirizine Hydrochloride Tablets
Marksans Pharma has received final approval from US Food & Drugs Administration for its Abbreviated New Drug Application (ANDA) for over the counter (OTC) Cetirizine Hydrochloride Tablets 5 mg and 10mg.

It is indicated for the treatment of the perennial allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes, running nose. The product will be marketed under store brand labels and is comparable to the brand Zyrtec®.

Previous News
  Godawari Power & Ispat Ltd leads losers in 'A' group
 ( Hot Pursuit - 31-Mar-23   15:01 )
  Marksans Pharma to convene AGM
 ( Corporate News - 11-Aug-21   18:44 )
  Board of Marksans Pharma appoints director
 ( Corporate News - 30-May-23   17:36 )
  Marksans Pharma to hold board meeting
 ( Corporate News - 02-Nov-19   18:59 )
  Marksans Pharma standalone net profit declines 58.73% in the March 2016 quarter
 ( Results - Announcements 30-May-16   16:09 )
  Marksans Pharma to table results
 ( Corporate News - 28-Oct-20   14:42 )
  eClerx Services Ltd leads gainers in 'A' group
 ( Hot Pursuit - 11-Jun-21   12:00 )
  Marksans Pharma consolidated net profit declines 9.65% in the June 2019 quarter
 ( Results - Announcements 10-Aug-19   11:37 )
  Marksans Pharma schedules AGM
 ( Corporate News - 03-Sep-18   12:11 )
  Marksans Pharma net profit rises 8.76% in the June 2014 quarter
 ( Results - Announcements 12-Aug-14   16:26 )
  Marksans Pharma revises board meeting date
 ( Corporate News - 28-Oct-21   09:30 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top